InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: ash111 post# 93844

Tuesday, 05/03/2016 3:06:11 PM

Tuesday, May 03, 2016 3:06:11 PM

Post# of 97237
KTOV ($20m cap,passed Phase 3) having another Solid day,6's here.https://www.accesswire.com/viewarticle.aspx?id=439525

a pocket change money for Pfizer to acquire.imo.Folks might drop Celebrex overnight and not worry about side effects and switch to KIT-302 (kitov's "improved Celebrex").imo

if kitov take only 10% of their market share alone(Pfizer had $1.7B in sales 2014-15 in average),on 70% profit margin,will brings her to almost $200m net income per year. 10 times market cap($20m current cap) might be equal to only one year net income. calculate PV and you ended up with a present value of $1B+. a major pharma can plop down $200m- $300m on a buyout for a billion dollar risk reward as well even before the drug hit the market (2017),imo.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.